Stock listing

Uniqure N.v.

Selected listing: A1XDTV · LS · EUR · DE

Uniqure N.v. (Lang & Schwarz: A1XDTV), Health Technology. Latest release Sep 29, 2026: UniQure Announces Additional Data from Ongoing Phase I/II Studies…

A1XDTV:LSEURDEUpdated October 9, 2026

Ticker: Lang & Schwarz: A1XDTV
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Uniqure N.v.

UniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec (AMT-130) in Huntington’s Disease Showing Continued Slowing of Disease Progression

September 29, 2026

UniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease

September 2, 2026

UniQure Announces Second Quarter 2026 Financial Results and Provides Company Update

July 29, 2026

UniQure to Announce Second Quarter 2026 Financial Results

July 22, 2026

UniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

June 25, 2026

All Uniqure N.v. news →

Events

Replays

uniQure N.V. (QURE) Q2 2026 Earnings Call
Wed, Jul 29, 2026 · 08:30 AM ET
Watch
uniQure N.V. (QURE) Q1 2026 Earnings Call
Tue, May 05, 2026 · 08:30 AM ET
Watch
uniQure N.V. (QURE) Q4 2025 Earnings Call
Mon, Mar 02, 2026 · 08:00 AM ET
Watch

Research Uniqure N.v.

Uniqure N.v. company profile

View the public company page for Uniqure N.v. on 6ix.

Uniqure N.v. news

Read company news and market updates connected to Uniqure N.v..

Uniqure N.v. investor events

Find investor webinars, events, and replay context for Uniqure N.v..